PRINCIPAL FINANCIAL GROUP INC - EMERGENT BIOSOLUTIONS INC ownership

EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 253 filers reported holding EMERGENT BIOSOLUTIONS INC in Q1 2022. The put-call ratio across all filers is 0.77 and the average weighting 0.0%.

Quarter-by-quarter ownership
PRINCIPAL FINANCIAL GROUP INC ownership history of EMERGENT BIOSOLUTIONS INC
ValueSharesWeighting
Q3 2023$133,579
-93.5%
39,288
-85.9%
0.00%
-100.0%
Q2 2023$2,052,994
-32.1%
279,319
-4.2%
0.00%
-50.0%
Q1 2023$3,021,370
-14.4%
291,638
-2.4%
0.00%
-33.3%
Q4 2022$3,529,135
-38.6%
298,826
+9.1%
0.00%
-40.0%
Q3 2022$5,748,000
-33.0%
273,851
-0.9%
0.01%
-16.7%
Q2 2022$8,575,000
-33.9%
276,250
-12.6%
0.01%
-25.0%
Q1 2022$12,976,000
-6.3%
316,016
-0.8%
0.01%0.0%
Q4 2021$13,849,000
+67.0%
318,588
+92.4%
0.01%
+60.0%
Q3 2021$8,293,000
-17.9%
165,627
+3.3%
0.01%
-28.6%
Q2 2021$10,104,000
-37.6%
160,403
-7.9%
0.01%
-36.4%
Q1 2021$16,185,000
+17.9%
174,206
+13.7%
0.01%
+10.0%
Q4 2020$13,731,000
-3.2%
153,244
+11.6%
0.01%
-16.7%
Q3 2020$14,186,000
-47.3%
137,286
-59.7%
0.01%
-50.0%
Q2 2020$26,940,000
+34.1%
340,664
-1.9%
0.02%
+9.1%
Q1 2020$20,084,000
+3.1%
347,111
-3.8%
0.02%
+37.5%
Q4 2019$19,474,000
+5.3%
360,954
+2.0%
0.02%0.0%
Q3 2019$18,498,000
+3.7%
353,829
-4.2%
0.02%0.0%
Q2 2019$17,841,000
-8.5%
369,298
-4.3%
0.02%
-11.1%
Q1 2019$19,489,000
-15.2%
385,769
-0.5%
0.02%
-25.0%
Q4 2018$22,972,000
-9.0%
387,518
+1.0%
0.02%
+9.1%
Q3 2018$25,254,000
+66.1%
383,624
+27.4%
0.02%
+57.1%
Q2 2018$15,207,000
-1.1%
301,194
+3.1%
0.01%
-6.7%
Q1 2018$15,377,000
+16.2%
292,075
+2.6%
0.02%
+25.0%
Q4 2017$13,230,000
+23.5%
284,708
+7.5%
0.01%
+20.0%
Q3 2017$10,716,000
+19.0%
264,917
-0.2%
0.01%
+11.1%
Q2 2017$9,004,000
+11.6%
265,531
-4.4%
0.01%
-10.0%
Q1 2017$8,066,000
-8.1%
277,770
+3.9%
0.01%
-9.1%
Q4 2016$8,779,000
+10.3%
267,324
+5.9%
0.01%
+10.0%
Q3 2016$7,960,000
+28.3%
252,450
+14.4%
0.01%
+11.1%
Q2 2016$6,204,000
-19.3%
220,626
+4.3%
0.01%
-18.2%
Q1 2016$7,692,000
-6.6%
211,606
+2.8%
0.01%
-8.3%
Q4 2015$8,239,000
+51.3%
205,923
+7.7%
0.01%
+33.3%
Q3 2015$5,446,000
-13.2%
191,172
+0.4%
0.01%0.0%
Q2 2015$6,276,000
+19.1%
190,470
+3.9%
0.01%
+12.5%
Q1 2015$5,271,000
+9.1%
183,259
+3.3%
0.01%0.0%
Q4 2014$4,831,000
+28.9%
177,422
+0.9%
0.01%
+33.3%
Q3 2014$3,748,000
-7.3%
175,880
-2.2%
0.01%
-14.3%
Q2 2014$4,041,000
-13.5%
179,927
-2.6%
0.01%
-12.5%
Q1 2014$4,669,000
+15.1%
184,753
+4.7%
0.01%0.0%
Q4 2013$4,057,000
+26.7%
176,462
+5.0%
0.01%
+14.3%
Q3 2013$3,203,000
+50.7%
168,114
+14.0%
0.01%
+40.0%
Q2 2013$2,126,000147,4600.01%
Other shareholders
EMERGENT BIOSOLUTIONS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Laurus Investment Counsel Inc. 120,504$10,797,0004.20%
SNYDER CAPITAL MANAGEMENT L P 723,477$64,824,0002.12%
Hillcrest Asset Management LLC 161,428$14,464,0001.97%
RICE HALL JAMES & ASSOCIATES, LLC 587,727$52,660,0001.85%
PALISADE CAPITAL MANAGEMENT, LP 579,009$51,879,0001.33%
Pier Capital, LLC 109,786$9,837,0001.04%
Paradiem, LLC 21,320$2,286,0000.97%
EARNEST PARTNERS LLC 1,390,735$124,610,0000.86%
Ridgewood Investments LLC 10,004$1,034,0000.82%
Tygh Capital Management, Inc. 56,334$5,048,0000.78%
View complete list of EMERGENT BIOSOLUTIONS INC shareholders